Cornelia Ulrich, MS, PhD

Languages

  • English
  • German

Academic Information

  • Departments: Population Health Sciences - Professor
  • Divisions: Cancer Population Science

Academic Office Information

  • 801-213-5716
  • Primary Children’s and Families’ Cancer Research Center
    Population Health Sciences, Huntsman Cancer Institute
    2000 Circle of Hope, Room: 4725 (HCI Res South)
    Salt Lake City, UT 84112

Academic Bio

Jon M. and Karen Huntsman Presidential Professor in Cancer Research
Director, Comprehensive Cancer Center at Huntsman Cancer Institute

Professor, Department of Population Health Sciences, University of Utah

Dr. Cornelia Ulrich is a cancer epidemiologist whose research focuses on lifestyle and biologic factors in cancer prevention and cancer prognosis. She is a Jon M. and Karen Huntsman Presidential Professor in Cancer Research and Director of the Comprehensive Cancer Center at Huntsman Cancer Institute (HCI). Ulrich previously served as Senior Director of Population Sciences at HCI and as Division Chief of Cancer Population Sciences in the Department of Population Health Sciences at the University of Utah. She came to HCI from the German Cancer Research Center and National Center for Tumor Diseases, where she was Director, as well as Head of the Department of Preventive Oncology. As Senior Director, Dr. Ulrich oversaw the Utah Population Database, Genetic Counseling Shared Resource, Biostatistics Shared Resource, Biospecimen and Molecular Pathology Shared Resource, and the Utah Cancer Registry. Dr. Ulrich leads an interdisciplinary team of scientists on research related to the prevention, epidemiology, prognosis, and survivorship of cancer. Major research areas include personalized cancer prevention with aspirin or other anti-inflammatory drugs; nutrition; connections between obesity, adipose tissue, and the progression of cancer; cancer screening; and the role of energy balance and physical activity in cancer prevention and cancer survivorship. Dr. Ulrich is also Principal Investigator of the HCI of the Total Cancer Care Protocol in the ORIEN network of cancer centers.

In her role as Director of the Comprehensive Cancer Center at HCI, Ulrich serves as principal investigator of HCI's Cancer Center Support Grant (CCSG).

Dr. Ulrich has authored more than 350 publications, including the book "Exercise, Energy Balance, and Cancer". She has served as PI of 23 active or completed funded projects, including a U01, nine R01 grants that involve multiple institutions, one R21, four R03s, one U54 Project PI, and seven European grants. Since 2001, she has been funded as PI of either NIH grants or awards made through the equivalent German and European granting organizations. She is an elected member to the European Academy of Cancer Sciences, and serves on numerous national and international advisory boards, committees, and editorial boards, including several of the National Institutes of Health, National Academies of Sciences, Engineering and Medicine, International Agency for Research on Cancer, and American Association of Cancer Research.

Research Statement

For more information, please visit: http://uofuhealth.utah.edu/huntsman/labs/ulrich/

Education History

Type School Degree
Doctoral Training University of Washington
Epidemiology
Ph.D.
Post Graduate Training University of Washington
Doctoral Studies Program: Health Services Research
Certificate
Graduate Training Oregon State University
Nutrition, Minor: Public Health
M.S.
Undergraduate University of Hohenheim
Nutrition Science
B.S.

Global Impact

Education History

Type School Degree Country
Undergraduate University of Hohenheim
Nutrition Science
B.S. Germany

Selected Publications

Journal Article

  1. Klett H, Balavarca Y, Toth R, Gigic B, Habermann N, Scherer D, Schrotz-King P, Ulrich A, Schirmacher P, Herpel E, Brenner H, Ulrich CM, Michels KB, Busch H, Boerries M (2018 May 3). Robust prediction of gene regulation in colorectal cancer tissues from DNA methylation profiles. Epigenetics, 1-12.
  2. Ulrich CM, Zhou QP, Ratcliffe SJ, Knafl K, Wallen GR, Richmond TS, Grady C (2018 Apr 1). Development and Preliminary Testing of the Perceived Benefit and Burden Scales for Cancer Clinical Trial Participation. J Empir Res Hum Res Ethics, 1556264618764730.
  3. Babaei M, Balavarca Y, Jansen L, Lemmens V, van Erning FN, van Eycken L, Vaes E, Sjovall A, Glimelius B, Ulrich CM, Schrotz-King P, Brenner H (2018 Apr 1). Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study. Int J Cancer, 142(7), 1480-1489.
  4. van Vulpen JK, Schmidt ME, Velthuis MJ, Wiskemann J, Schneeweiss A, Vermeulen RCH, Habermann N, Ulrich CM, Peeters PHM, van der Wall E, May AM, Steindorf K (2018 Apr). Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy. Breast Cancer Res Treat, 168(2), 421-431.
  5. Schmidt ME, Wiskemann J, Schneeweiss A, Potthoff K, Ulrich CM, Steindorf K (2018 Mar 15). Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up. Int J Cancer, 142(6), 1148-1157.
  6. Babaei M, Jansen L, Balavarca Y, Sjovall A, Bos A, van de Velde T, Moreau M, Liberale G, Goncalves AF, Bento MJ, Ulrich CM, Schrotz-King P, Lemmens V, Glimelius B, Brenner H (2018 Mar). Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes. Clin Colorectal Cancer, 17(1), e129-e142.
  7. Delphan M, Lin T, Liesenfeld DB, Nattenmuller J, Bohm JT, Gigic B, Habermann N, Zielske L, Schrotz-King P, Schneider M, Ulrich A, Kauczor HU, Ulrich CM, Ose J (2018 Mar). Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study.LID - 22 [pii]LID - 10.1007/s11306-017-1314-8 [doi]. Metabolomics, 2018(14).
  8. Gigic B, Boeing H, Toth R, Bohm J, Habermann N, Scherer D, Schrotz-King P, Abbenhardt-Martin C, Skender S, Brenner H, Chang-Claude J, Hoffmeister M, Syrjala K, Jacobsen PB, Schneider M, Ulrich A, Ulrich CM (2018 Jan). Associations Between Dietary Patterns and Longitudinal Quality of Life Changes in Colorectal Cancer Patients: The ColoCare Study. Nutr Cancer, 70(1), 51-60.
  9. Sheth H, Northwood E, Ulrich CM, Scherer D, Elliott F, Barrett JH, Forman D, Wolf CR, Smith G, Jackson MS, Santibanez-Koref M, Haile R, Casey G, Jenkins M, Win AK, Hopper JL, Marchand LL, Lindor NM, Thibodeau SN, Potter JD, Burn J, Bishop DT (2018). Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations. PLoS ONE, 13(2), e0192223.
  10. Barrow TM, Klett H, Toth R, Bohm J, Gigic B, Habermann N, Scherer D, Schrotz-King P, Skender S, Abbenhardt-Martin C, Zielske L, Schneider M, Ulrich A, Schirmacher P, Herpel E, Brenner H, Busch H, Boerries M, Ulrich CM, Michels KB (2017 Nov). Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study. J Pathol, 243(3), 366-375.
  11. Wiskemann J, Schmidt ME, Klassen O, Debus J, Ulrich CM, Potthoff K, Steindorf K (2017 Nov). Effects of 12-week resistance training during radiotherapy in breast cancer patients. Scand J Med Sci Sports, 27(11), 1500-1510.
  12. Clauss D, Tjaden C, Hackert T, Schneider L, Ulrich CM, Wiskemann J, Steindorf K (2017 Sep). Cardiorespiratory fitness and muscle strength in pancreatic cancer patients. Support Care Cancer, 25(9), 2797-2807.
  13. Jewel Samadder N, Valentine JF, Guthery S, Singh H, Bernstein CN, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Bronner M, Ulrich CM, Burt RW, Curtin K, Smith KR (2017 Aug). Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah. Dig Dis Sci, 62(8), 2126-2132.
  14. Toth R, Scherer D, Kelemen LE, Risch A, Hazra A, Balavarca Y, Issa JJ, Moreno V, Eeles RA, Ogino S, Wu X, Ye Y, Hung RJ, Goode EL, Ulrich CM (2017 Jun). Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium. Cancer Epidemiol Biomarkers Prev, 26(6), 816-825.
  15. Khallouki F, Voggel J, Breuer A, Klika KD, Ulrich CM, Owen RW (2017 Apr 15). Comparison of the major polyphenols in mature Argan fruits from two regions of Morocco. Food Chem, 221, 1034-1040.
  16. Klassen O, Schmidt ME, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K, Wiskemann J (2017 Apr). Muscle strength in breast cancer patients receiving different treatment regimes. J Cachexia Sarcopenia Muscle, 8(2), 305-316.
  17. Steindorf K, Wiskemann J, Ulrich CM, Schmidt ME (2017 Apr). Effects of exercise on sleep problems in breast cancer patients receiving radiotherapy: a randomized clinical trial. Breast Cancer Res Treat, 162(3), 489-499.
  18. Schmidt ME, Wiskemann J, Ulrich CM, Schneeweiss A, Steindorf K (2017 Apr). Self-reported physical activity behavior of breast cancer survivors during and after adjuvant therapy: 12 months follow-up of two randomized exercise intervention trials. Acta Oncol, 56(4), 618-627.
  19. Bohm J, Pianka F, Stuttgen N, Rho J, Gigic B, Zhang Y, Habermann N, Schrotz-King P, Abbenhardt-Martin C, Zielske L, Lampe PD, Ulrich A, Diener MK, Ulrich CM (2017 Mar). Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study. Surgery, 161(3), 808-817.
  20. Khallouki F, Breuer A, Merieme E, Ulrich CM, Owen RW (2017 Feb 5). Characterization and quantitation of the polyphenolic compounds detected in methanol extracts of Pistacia atlantica Desf. fruits from the Guelmim region of Morocco. J Pharm Biomed Anal, 134, 310-318.
  21. Skender S, Bohm J, Schrotz-King P, Chang-Claude J, Siegel EM, Steindorf K, Owen RW, Ose J, Hoffmeister M, Brenner H, Ulrich CM (2017 Feb-Mar). Plasma 25-Hydroxyvitamin D3 Levels in Colorectal Cancer Patients and Associations with Physical Activity. Nutr Cancer, 69(2), 229-237.
  22. Ulrich CM (2017). What Nurse Bioethicists Bring to Bioethics: <i>The Journey of a Nurse Bioethicist</i>. Perspect Biol Med, 60(1), 33-46.
  23. Himbert C, Thompson H, Ulrich CM (2017). Effects of Intentional Weight Loss on Markers of Oxidative Stress, DNA Repair and Telomere Length - a Systematic Review. Obes Facts, 10(6), 648-665.
  24. Karami S, Han Y, Pande M, Cheng I, Rudd J, Pierce BL, Nutter EL, Schumacher FR, Kote-Jarai Z, Lindstrom S, Witte JS, Fang S, Han J, Kraft P, Hunter DJ, Song F, Hung RJ, McKay J, Gruber SB, Chanock SJ, Risch A, Shen H, Haiman CA, Boardman L, Ulrich CM, Casey G, Peters U, Amin Al Olama A, Berchuck A, Berndt SI, Bezieau S, Brennan P, Brenner H, Brinton L, Caporaso N, Chan AT, Chang-Claude J, Christiani DC, Cunningham JM, Easton D, Eeles RA, Eisen T, Gala M, Gallinger SJ, Gayther SA, Goode EL, Gronberg H, Henderson BE, Houlston R, Joshi AD, Kury S, Landi MT, Le Marchand L, Muir K, Newcomb PA, Permuth-Wey J, Pharoah P, Phelan C, Potter JD, Ramus SJ, Risch H, Schildkraut J, Slattery ML, Song H, Wentzensen N, White E, Wiklund F, Zanke BW, Sellers TA, Zheng W, Chatterjee N, Amos CI, Doherty JA (2016 Dec 15). Telomere structure and maintenance gene variants and risk of five cancer types. Int J Cancer, 139(12), 2655-2670.
  25. Schubel R, Graf ME, Nattenmuller J, Nabers D, Sookthai D, Gruner LF, Johnson T, Schlett CL, von Stackelberg O, Kirsten R, Habermann N, Kratz M, Kauczor HU, Ulrich CM, Kaaks R, Kuhn T (2016 Nov). The effects of intermittent calorie restriction on metabolic health: Rationale and study design of the HELENA Trial. Contemp Clin Trials, 51, 28-33.
  26. Gong J, Hutter CM, Newcomb PA, Ulrich CM, Bien SA, Campbell PT, Baron JA, Berndt SI, Bezieau S, Brenner H, Casey G, Chan AT, Chang-Claude J, Du M, Duggan D, Figueiredo JC, Gallinger S, Giovannucci EL, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jeon J, Jenkins MA, Kocarnik J, Kury S, Le Marchand L, Lin Y, Lindor NM, Nishihara R, Ogino S, Potter JD, Rudolph A, Schoen RE, Schrotz-King P, Seminara D, Slattery ML, Thibodeau SN, Thornquist M, Toth R, Wallace R, White E, Jiao S, Lemire M, Hsu L, Peters U (2016 Oct). Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer. PLoS Genet, 12(10), e1006296.
  27. Wiskemann J, Hummler S, Diepold C, Keil M, Abel U, Steindorf K, Beckhove P, Ulrich CM, Steins M, Thomas M (2016 Jul 19). POSITIVE study: physical exercise program in non-operable lung cancer patients undergoing palliative treatment. BMC Cancer, 16, 499.
  28. Kap EJ, Seibold P, Scherer D, Habermann N, Balavarca Y, Jansen L, Zucknick M, Becker N, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J (2016 Jun 15). SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients. Int J Cancer, 138(12), 2993-3001.
  29. Babaei M, Balavarca Y, Jansen L, Gondos A, Lemmens V, Sjovall A, Brge Johannesen T, Moreau M, Gabriel L, Goncalves AF, Bento MJ, van de Velde T, Kempfer LR, Becker N, Ulrich A, Ulrich CM, Schrotz-King P, Brenner H (2016 May). Minimally Invasive Colorectal Cancer Surgery in Europe: Implementation and Outcomes. Medicine (Baltimore), 95(22), e3812.
  30. Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Akerley W, Gilcrease G, Ulrich CM, Burt RW, Curtin K (2016 Mar). Familial Risk in Patients With Carcinoma of Unknown Primary. JAMA Oncol, 2(3), 340-6.
  31. Schmidt ME, Semik J, Habermann N, Wiskemann J, Ulrich CM, Steindorf K (2016 Feb). Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients. Brain Behav Immun, 52, 98-105.
  32. Schmidt ME, Meynkohn A, Habermann N, Wiskemann J, Oelmann J, Hof H, Wessels S, Klassen O, Debus J, Potthoff K, Steindorf K, Ulrich CM (2016 Feb 1). Resistance Exercise and Inflammation in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy: Mediation Analysis From a Randomized, Controlled Intervention Trial. Int J Radiat Oncol Biol Phys, 94(2), 329-37.
  33. Garcia-Albeniz X, Rudolph A, Hutter C, White E, Lin Y, Rosse SA, Figueiredo JC, Harrison TA, Jiao S, Brenner H, Casey G, Hudson TJ, Thornquist M, Le Marchand L, Potter J, Slattery ML, Zanke B, Baron JA, Caan BJ, Chanock SJ, Berndt SI, Stelling D, Fuchs CS, Hoffmeister M, Butterbach K, Du M, James Gauderman W, Gunter MJ, Lemire M, Ogino S, Lin J, Hayes RB, Haile RW, Schoen RE, Warnick GS, Jenkins MA, Thibodeau SN, Schumacher FR, Lindor NM, Kolonel LN, Hopper JL, Gong J, Seminara D, Pflugeisen BM, Ulrich CM, Qu C, Duggan D, Cotterchio M, Campbell PT, Carlson CS, Newcomb PA, Giovannucci E, Hsu L, Chan AT, Peters U, Chang-Claude J (2016 Jan 19). CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. Br J Cancer, 114(2), 221-9.
  34. Liesenfeld DB, Botma A, Habermann N, Toth R, Weigel C, Popanda O, Klika KD, Potter JD, Lampe JW, Ulrich CM (2016 Jan). Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial. Cancer Epidemiol Biomarkers Prev, 25(1), 180-7.
  35. Ungar N, Sieverding M, Weidner G, Ulrich CM, Wiskemann J (2016). A self-regulation-based intervention to increase physical activity in cancer patients. Psychol Health Med, 21(2), 163-75.
  36. Pfutze K, Benner A, Hoffmeister M, Jansen L, Yang R, Blaker H, Herpel E, Ulrich A, Ulrich CM, Chang-Claude J, Brenner H, Burwinkel B (2015 Dec). Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy. Genomics, 106(6), 348-54.
  37. Scharhag-Rosenberger F, Kuehl R, Klassen O, Schommer K, Schmidt ME, Ulrich CM, Wiskemann J, Steindorf K (2015 Dec). Exercise training intensity prescription in breast cancer survivors: validity of current practice and specific recommendations. J Cancer Surviv, 9(4), 612-9.
  38. Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Ahnen D, Singh H, Ulrich CM, Burt RW, Curtin K (2015 Dec). Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis. Clin Gastroenterol Hepatol, 13(13), 2305-11.e1-2.
  39. Kap EJ, Seibold P, Richter S, Scherer D, Habermann N, Balavarca Y, Jansen L, Becker N, Pfutze K, Popanda O, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J (2015 Dec). Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer. Pharmacogenomics J, 15(6), 505-12.
  40. Hung RJ, Ulrich CM, Goode EL, Brhane Y, Muir K, Chan AT, Marchand LL, Schildkraut J, Witte JS, Eeles R, Boffetta P, Spitz MR, Poirier JG, Rider DN, Fridley BL, Chen Z, Haiman C, Schumacher F, Easton DF, Landi MT, Brennan P, Houlston R, Christiani DC, Field JK, Bickeboller H, Risch A, Kote-Jarai Z, Wiklund F, Gronberg H, Chanock S, Berndt SI, Kraft P, Lindstrom S, Al Olama AA, Song H, Phelan C, Wentzensen N, Peters U, Slattery ML, Sellers TA, Casey G, Gruber SB, Hunter DJ, Amos CI, Henderson B (2015 Nov). Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.LID - 10.1093/jnci/djv246 [doi]LID - djv246 [pii]. J Natl Cancer Inst, 107(11).
  41. Cheng TY, Makar KW, Neuhouser ML, Miller JW, Song X, Brown EC, Beresford SA, Zheng Y, Poole EM, Galbraith RL, Duggan DJ, Habermann N, Bailey LB, Maneval DR, Caudill MA, Toriola AT, Green R, Ulrich CM (2015 Oct 15). Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study. Cancer, 121(20), 3684-91.
  42. Wiskemann J, Kuehl R, Dreger P, Huber G, Kleindienst N, Ulrich CM, Bohus M (2015 Sep 7). Physical Exercise Training versus Relaxation in Allogeneic stem cell transplantation (PETRA Study) - Rationale and design of a randomized trial to evaluate a yearlong exercise intervention on overall survival and side-effects after allogeneic stem cell transplantation. BMC Cancer, 15, 619.
  43. Neuhouser ML, Cheng TY, Beresford SA, Brown E, Song X, Miller JW, Zheng Y, Thomson CA, Shikany JM, Vitolins MZ, Rohan T, Green R, Ulrich CM (2015 Aug 15). Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study. Int J Cancer, 137(4), 930-9.
  44. Liesenfeld DB, Grapov D, Fahrmann JF, Salou M, Scherer D, Toth R, Habermann N, Bohm J, Schrotz-King P, Gigic B, Schneider M, Ulrich A, Herpel E, Schirmacher P, Fiehn O, Lampe JW, Ulrich CM (2015 Aug). Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study. Am J Clin Nutr, 102(2), 433-43.
  45. Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M, Farris AB, Figueiredo JC, Gallinger S, Green RC, Haile RW, Hopper JL, Jenkins MA, Le Marchand L, Makar KW, McLaughlin JR, Potter JD, Renehan AG, Sinicrope FA, Thibodeau SN, Ulrich CM, Win AK, Lindor NM, Limburg PJ (2015 Aug). Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype. Cancer Epidemiol Biomarkers Prev, 24(8), 1229-38.
  46. Liesenfeld DB, Habermann N, Toth R, Owen RW, Frei E, Staffa J, Schrotz-King P, Klika KD, Ulrich CM (2015 Aug). Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare). Metabolomics (Los Angel), 11(4), 998-1012.
  47. Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K (2015 Jul 15). Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial. Int J Cancer, 137(2), 471-80.
  48. Khallouki F, Haubner R, Ricarte I, Erben G, Klika K, Ulrich CM, Owen RW (2015 Jul 15). Identification of polyphenolic compounds in the flesh of Argan (Morocco) fruits. Food Chem, 179, 191-8.
  49. Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucc EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Kury S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G, Gruber SB, Peters U (2015 Jul 7). Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun, 6, 7138.
  50. Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, Chan AT, Locke AE, Kahali B, Justice AE, Pers TH, Gallinger S, Hayes RB, Baron JA, Caan BJ, Ogino S, Berndt SI, Chanock SJ, Casey G, Haile RW, Du M, Harrison TA, Thornquist M, Duggan DJ, Le Marchand L, Lindor NM, Seminara D, Song M, Wu K, Thibodeau SN, Cotterchio M, Win AK, Jenkins MA, Hopper JL, Ulrich CM, Potter JD, Newcomb PA, Hoffmeister M, Brenner H, White E, Hsu L, Campbell PT (2015 Jul). Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev, 24(7), 1024-31.
  51. Skender S, Schrotz-King P, Bohm J, Abbenhardt C, Gigic B, Chang-Claude J, Siegel EM, Steindorf K, Ulrich CM (2015 Jun 6). Repeat physical activity measurement by accelerometry among colorectal cancer patients--feasibility and minimal number of days of monitoring. BMC Res Notes, 8, 222.
  52. Joshi AD, Kim A, Lewinger JP, Ulrich CM, Potter JD, Cotterchio M, Le Marchand L, Stern MC (2015 Jun). Meat intake, cooking methods, dietary carcinogens, and colorectal cancer risk: findings from the Colorectal Cancer Family Registry. Cancer Med, 4(6), 936-52.
  53. Kuehl R, Scharhag-Rosenberger F, Schommer K, Schmidt ME, Dreger P, Huber G, Bohus M, Ulrich CM, Wiskemann J (2015 May). Exercise intensity classification in cancer patients undergoing allogeneic HCT. Med Sci Sports Exerc, 47(5), 889-95.
  54. Habermann N, Makar KW, Abbenhardt C, Xiao L, Wang CY, Utsugi HK, Alfano CM, Campbell KL, Duggan C, Foster-Schubert KE, Mason CE, Imayama I, Blackburn GL, Potter JD, McTiernan A, Ulrich CM (2015 May). No effect of caloric restriction or exercise on radiation repair capacity. Med Sci Sports Exerc, 47(5), 896-904.
  55. Bohanes P, Rankin CJ, Blanke CD, Winder T, Ulrich CM, Smalley SR, Rich TA, Martensen JA, Benson AB 3rd, Mayer RJ, Cripps CM, Danenberg K, Makar KW, Zhang W, Benedetti JK, Lenz HJ (2015 Apr 1). Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation. Clin Cancer Res, 21(7), 1583-90.
  56. Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, Chan AT, Esko T, Wood AR, Yang J, Vedantam S, Gustafsson S, Pers TH, Baron JA, Bezieau S, Kury S, Ogino S, Berndt SI, Casey G, Haile RW, Du M, Harrison TA, Thornquist M, Duggan DJ, Le Marchand L, Lemire M, Lindor NM, Seminara D, Song M, Thibodeau SN, Cotterchio M, Win AK, Jenkins MA, Hopper JL, Ulrich CM, Potter JD, Newcomb PA, Schoen RE, Hoffmeister M, Brenner H, White E, Hsu L, Campbell PT (2015 Apr). Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol, 44(2), 662-72.
  57. Gollhofer SM, Wiskemann J, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Hof H, Potthoff K, Steindorf K (2015 Mar 27). Factors influencing participation in a randomized controlled resistance exercise intervention study in breast cancer patients during radiotherapy. BMC Cancer, 15, 186.
  58. Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chang-Claude J, Chanock SJ, Cotterchio M, Duggan D, Figueiredo JC, Fuchs CS, Giovannucci EL, Gong J, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Jiao S, Lindor NM, Lemire M, Le Marchand L, Newcomb PA, Ogino S, Pflugeisen BM, Potter JD, Qu C, Rosse SA, Rudolph A, Schoen RE, Schumacher FR, Seminara D, Slattery ML, Thibodeau SN, Thomas F, Thornquist M, Warnick GS, Zanke BW, Gauderman WJ, Peters U, Hsu L, Chan AT (2015 Mar 17). Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA, 313(11), 1133-42.
  59. Ulrich CM, Wallen GR, Cui N, Chittams J, Sweet M, Plemmons D (2015 Mar-Apr). Establishing good collaborative research practices in the responsible conduct of research in nursing science. Nurs Outlook, 63(2), 171-80.
  60. Yu M, Carter KT, Makar KW, Vickers K, Ulrich CM, Schoen RE, Brenner D, Markowitz SD, Grady WM (2015). MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles. Epigenetics, 10(9), 803-9.
  61. Wild CP, Bucher JR, de Jong BW, Dillner J, von Gertten C, Groopman JD, Herceg Z, Holmes E, Holmila R, Olsen JH, Ringborg U, Scalbert A, Shibata T, Smith MT, Ulrich C, Vineis P, McLaughlin J (2015 Jan). Translational cancer research: balancing prevention and treatment to combat cancer globally. J Natl Cancer Inst, 107(1), 353.
  62. Ulrich CM, Grady C (2015 Jan-Feb). Cardiopulmonary resuscitation for Ebola patients: ethical considerations. Nurs Outlook, 63(1), 16-8.
  63. Ungar N, Sieverding M, Ulrich CM, Wiskemann J (2015). What explains the intention to be physically active in cancer patients? Different determinants for active and insufficiently active patients. J Psychosoc Oncol, 33(1), 15-33.
  64. Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng TY, Miller JW, Green R, Lane DS, Beresford SA, Caudill MA (2014 Dec 15). Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study. Cancer Res, 74(24), 7442-52.
  65. Du M, Zhang X, Hoffmeister M, Schoen RE, Baron JA, Berndt SI, Brenner H, Carlson CS, Casey G, Chan AT, Curtis KR, Duggan D, Gauderman WJ, Giovannucci EL, Gong J, Harrison TA, Hayes RB, Henderson BE, Hopper JL, Hsu L, Hudson TJ, Hutter CM, Jenkins MA, Jiao S, Kocarnik JM, Kolonel LN, Le Marchand L, Lin Y, Newcomb PA, Rudolph A, Seminara D, Thornquist MD, Ulrich CM, White E, Wu K, Zanke BW, Campbell PT, Slattery ML, Peters U, Chang-Claude J, Potter JD (2014 Dec). No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 23(12), 2971-6.
  66. Ristau J, Staffa J, Schrotz-King P, Gigic B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M, Ulrich CM, Habermann N (2014 Dec). Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer. Cancer Epidemiol Biomarkers Prev, 23(12), 2632-7.
  67. Lucas MS, Barakat LP, Jones NL, Ulrich CM, Deatrick JA (2014 Winter). Expectations for function and independence by childhood brain tumors survivors and their mothers. Narrat Inq Bioeth, 4(3), 233-51.
  68. Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Bohm J, Brunetti F, Habermann N, Hercog R, Koch M, Luciani A, Mende DR, Schneider MA, Schrotz-King P, Tournigand C, Tran Van Nhieu J, Yamada T, Zimmermann J, Benes V, Kloor M, Ulrich CM, von Knebel Doeberitz M, Sobhani I, Bork P (2014 Nov 28). Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol, 10, 766.
  69. Ulrich CM (2014 Nov 7). Ebola is causing moral distress among African healthcare workers. BMJ, 349, g6672.
  70. Steindorf K, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Habermann N, Beckhove P, Owen R, Debus J, Wiskemann J, Potthoff K (2014 Nov). Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life. Ann Oncol, 25(11), 2237-43.
  71. Ulrich CM, Rankin C, Toriola AT, Makar KW, Altug-Teber O, Benedetti JK, Holmes RS, Smalley SR, Blanke CD, Lenz HJ (2014 Nov 1). Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304). Cancer, 120(21), 3329-37.
  72. Pfundstein B, Haubner R, Wurtele G, Gehres N, Ulrich CM, Owen RW (2014 Oct 22). Pilot walnut intervention study of urolithin bioavailability in human volunteers. J Agric Food Chem, 62(42), 10264-73.
  73. Resler AJ, Makar KW, Heath L, Whitton J, Potter JD, Poole EM, Habermann N, Scherer D, Duggan D, Wang H, Lindor NM, Passarelli MN, Baron JA, Newcomb PA, Marchand LL, Ulrich CM (2014 Sep). Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry. Carcinogenesis, 35(9), 2121-6.
  74. Kantor ED, Hutter CM, Minnier J, Berndt SI, Brenner H, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Cotterchio M, Du M, Duggan D, Fuchs CS, Giovannucci EL, Gong J, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Jenkins MA, Jiao S, Kolonel LN, Le Marchand L, Lemire M, Ma J, Newcomb PA, Ochs-Balcom HM, Pflugeisen BM, Potter JD, Rudolph A, Schoen RE, Seminara D, Slattery ML, Stelling DL, Thomas F, Thornquist M, Ulrich CM, Warnick GS, Zanke BW, Peters U, Hsu L, White E (2014 Sep). Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci. Cancer Epidemiol Biomarkers Prev, 23(9), 1824-33.
  75. Luo Y, Wong CJ, Kaz AM, Dzieciatkowski S, Carter KT, Morris SM, Wang J, Willis JE, Makar KW, Ulrich CM, Lutterbaugh JD, Shrubsole MJ, Zheng W, Markowitz SD, Grady WM (2014 Aug). Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology, 147(2), 418-29.e8.
  76. Kap EJ, Richter S, Rudolph A, Jansen L, Ulrich A, Hoffmeister M, Ulrich CM, Brenner H, Chang-Claude J (2014 Jul). Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin. Pharmacogenet Genomics, 24(7), 340-7.
  77. Scherer D, Koepl LM, Poole EM, Balavarca Y, Xiao L, Baron JA, Hsu L, Coghill AE, Campbell PT, Kleinstein SE, Figueiredo JC, Lampe JW, Buck K, Potter JD, Kulmacz RJ, Jenkins MA, Hopper JL, Win AK, Newcomb PA, Ulrich CM, Makar KW (2014 Jul). Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry. Genes Chromosomes Cancer, 53(7), 568-78.
  78. Klassen O, Schmidt ME, Scharhag-Rosenberger F, Sorkin M, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K, Wiskemann J (2014 May 16). Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy. Acta Oncol, 1-10.
  79. Spector JT, De Roos AJ, Ulrich CM, Sheppard L, Sjodin A, Wener MH, Wood B, McTiernan A (2014 May). Plasma polychlorinated biphenyl concentrations and immune function in postmenopausal women. Environ Res, 131, 174-80.
  80. Fiederling J, Ulrich CM, Hemminki K, Haug U (2014 May). Consideration of family history of cancer in medical routine: a survey in the primary care setting in Germany. Eur J Cancer Prev, 23(3), 199-205.
  81. Abbenhardt C, Miller JW, Song X, Brown EC, Cheng TY, Wener MH, Zheng Y, Toriola AT, Neuhouser ML, Beresford SA, Makar KW, Bailey LB, Maneval DR, Green R, Manson JE, Van Horn L, Ulrich CM (2014 May). Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women. J Nutr, 144(5), 714-21.
  82. Kuehr L, Wiskemann J, Abel U, Ulrich CM, Hummler S, Thomas M (2014 Apr). Exercise in patients with non-small cell lung cancer. Med Sci Sports Exerc, 46(4), 656-63.
  83. Figueiredo JC, Hsu L, Hutter CM, Lin Y, Campbell PT, Baron JA, Berndt SI, Jiao S, Casey G, Fortini B, Chan AT, Cotterchio M, Lemire M, Gallinger S, Harrison TA, Le Marchand L, Newcomb PA, Slattery ML, Caan BJ, Carlson CS, Zanke BW, Rosse SA, Brenner H, Giovannucci EL, Wu K, Chang-Claude J, Chanock SJ, Curtis KR, Duggan D, Gong J, Haile RW, Hayes RB, Hoffmeister M, Hopper JL, Jenkins MA, Kolonel LN, Qu C, Rudolph A, Schoen RE, Schumacher FR, Seminara D, Stelling DL, Thibodeau SN, Thornquist M, Warnick GS, Henderson BE, Ulrich CM, Gauderman WJ, Potter JD, White E, Peters U (2014 Apr). Genome-wide diet-gene interaction analyses for risk of colorectal cancer. PLoS Genet, 10(4), e1004228.
  84. Wiskemann J, Kuehl R, Dreger P, Schwerdtfeger R, Huber G, Ulrich CM, Jaeger D, Bohus M (2014 Mar). Efficacy of exercise training in SCT patients--who benefits most? Bone Marrow Transplant, 49(3), 443-8.
  85. Bae S, Ulrich CM, Bailey LB, Malysheva O, Brown EC, Maneval DR, Neuhouser ML, Cheng TY, Miller JW, Zheng Y, Xiao L, Hou L, Song X, Buck K, Beresford SA, Caudill MA (2014 Mar). Impact of folic acid fortification on global DNA methylation and one-carbon biomarkers in the Women's Health Initiative Observational Study cohort. Epigenetics, 9(3), 396-403.
  86. Slota C, Ulrich CM, Miller-Davis C, Baker K, Wallen GR (2014). Qualitative inquiry: a method for validating patient perceptions of palliative care while enrolled on a cancer clinical trial. BMC Palliative Care, 13, 43.
  87. Hummler S, Thomas M, Hoffmann B, Gartner P, Zoz M, Huber G, Ulrich CM, Wiskemann J (2014). Physical performance and psychosocial status in lung cancer patients: results from a pilot study. Oncol Res Treat, 37(1-2), 36-41.
  88. Huebner J, Marienfeld S, Abbenhardt C, Ulrich CM, Muenstedt K, Micke O, Muecke R, Loeser C (). Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice. Anticancer Res, 34, 39-48.
  89. Liesenfeld DB, Habermann N, Owen RW, Scalbert A, Ulrich CM (2013 Dec). Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiol Biomarkers Prev, 22(12), 2182-201.
  90. Makar KW, Poole EM, Resler AJ, Seufert B, Curtin K, Kleinstein SE, Duggan D, Kulmacz RJ, Hsu L, Whitton J, Carlson CS, Rimorin CF, Caan BJ, Baron JA, Potter JD, Slattery ML, Ulrich CM (2013 Dec). COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control, 24(12), 2059-75.
  91. Kantor ED, Ulrich CM, Owen RW, Schmezer P, Neuhouser ML, Lampe JW, Peters U, Shen DD, Vaughan TL, White E (2013 Dec). Specialty supplement use and biologic measures of oxidative stress and DNA damage. Cancer Epidemiol Biomarkers Prev, 22(12), 2312-22.
  92. Wang H, Taverna D, Stram DO, Fortini BK, Cheng I, Wilkens LR, Burnett T, Makar KW, Lindor NM, Hopper JL, Gallinger S, Baron JA, Haile R, Kolonel LN, Henderson BE, Newcomb PA, Casey G, Duggan D, Ulrich CM, Le Marchand L (2013 Nov). Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 22(11), 2094-101.
  93. Cadmus-Bertram L, Littman AJ, Ulrich CM, Stovall R, Ceballos RM, McGregor BA, Wang CY, Ramaprasad J, McTiernan A (2013 Sep). Predictors of adherence to a 26-week viniyoga intervention among post-treatment breast cancer survivors. J Altern Complement Med, 19(9), 751-8.
  94. Sherwood AM, Emerson RO, Scherer D, Habermann N, Buck K, Staffa J, Desmarais C, Halama N, Jaeger D, Schirmacher P, Herpel E, Kloor M, Ulrich A, Schneider M, Ulrich CM, Robins H (2013 Sep). Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue. Cancer Immunol Immunother, 62(9), 1453-61.
  95. Kraus S, Hummler S, Toriola AT, Poole EM, Scherer D, Kotzmann J, Makar KW, Kazanov D, Galazan L, Naumov I, Coghill AE, Duggan D, Gigic B, Arber N, Ulrich CM (2013 Aug). Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study. Pharmacogenet Genomics, 23(8), 428-37.
  96. Abbenhardt C, McTiernan A, Alfano CM, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Toriola AT, Potter JD, Mason C, Xiao L, Blackburn GL, Bain C, Ulrich CM (2013 Aug). Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med, 274(2), 163-75.
  97. Toriola AT, Cheng TY, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SA, Gunter MJ, Caudill MA, Ulrich CM (2013 Jun 1). Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer, 132(11), 2648-58.
  98. Kleinstein SE, Heath L, Makar KW, Poole EM, Seufert BL, Slattery ML, Xiao L, Duggan DJ, Hsu L, Curtin K, Koepl L, Muehling J, Taverna D, Caan BJ, Carlson CS, Potter JD, Ulrich CM (2013 May). Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes Chromosomes Cancer, 52(5), 437-49.
  99. Miller JW, Beresford SA, Neuhouser ML, Cheng TY, Song X, Brown EC, Zheng Y, Rodriguez B, Green R, Ulrich CM (2013 Apr). Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort. Am J Clin Nutr, 97(4), 827-34.
  100. Liu AY, Scherer D, Poole E, Potter JD, Curtin K, Makar K, Slattery ML, Caan BJ, Ulrich CM (2013 Apr). Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res, 57(4), 721-34.
  101. Villasenor A, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, Baumgartner R, Ulrich CM, Hollis BW, McTiernan A, Neuhouser ML (2013 Apr). Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control, 24(4), 759-67.
  102. Miller JW, Ulrich CM (2013 Mar 23). Folic acid and cancer--where are we today? Lancet, 381(9871), 974-6.
  103. Campbell KL, Foster-Schubert KE, Makar KW, Kratz M, Hagman D, Schur EA, Habermann N, Horton M, Abbenhardt C, Kuan LY, Xiao L, Davison J, Morgan M, Wang CY, Duggan C, McTiernan A, Ulrich CM (2013 Mar). Gene expression changes in adipose tissue with diet- and/or exercise-induced weight loss. Cancer Prev Res (Phila), 6(3), 217-31.
  104. Zschabitz S, Cheng TY, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Maneval DR, Beresford SA, Lane D, Shikany JM, Ulrich CM (2013 Feb). B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort. Am J Clin Nutr, 97(2), 332-43.
  105. Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM (2013 Jan). CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer Causes Control, 24(1), 47-54.
  106. Carvalho AL, Annoni R, Torres LH, Durao AC, Shimada AL, Almeida FM, Hebeda CB, Lopes FD, Dolhnikoff M, Martins MA, Silva LF, Farsky SH, Saldiva PH, Ulrich CM, Owen RW, Marcourakis T, Trevisan MT, Mauad T (2013). Anacardic acids from cashew nuts ameliorate lung damage induced by exposure to diesel exhaust particles in mice. Evid Based Complement Alternat Med, 2013, 549879.
  107. De Souza JRR, Feitosa JPA, Ricardo NMPS, Trevisan MTS, de Paula HCB, Ulrich CM, Owen RW (). Spray-drying encapsulation of mangiferin using natural polymers. Food Hydrocolloids, 33, 10-18.
  108. Potthoff K, Schmidt ME, Wiskemann J, Hof H, Klassen O, Habermann N, Beckhove P, Debus J, Ulrich CM, Steindorf K (2013). Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study. BMC Cancer, 13, 162.
  109. Ulrich CM, Toriola AT, Siegel EM, Brenner H, Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister M, Becher H, Shibata D, Vickers K, Rush S, Makar KW, Wrtele G, Haubner R, Sellers TA, Grady W (). Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study. J Nutr Sci, 2, 1-6.
  110. Schmidt ME, Wiskemann J, Krakowski-Roosen H, Knicker AJ, Habermann N, Schneeweiss A, Ulrich CM, Steindorf K (2013 Jan). Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: design and rationale of a randomized controlled trial (BEATE study). Contemp Clin Trials, 34(1), 117-25.
  111. Ulrich CM, Toriola AT, Siegel EM, Brenner H, Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister M, Becher H, Shibata D, Vickers K, Rush SK, Makar K, Wurtele G, Haubner R, Sellers TA, Grady W (2013). Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study. J Nutr Sci, 2, e9.
  112. Mason C, Foster-Schubert KE, Imayama I, Xiao L, Kong A, Campbell KL, Duggan CR, Wang CY, Alfano CM, Ulrich CM, Blackburn GL, McTiernan A (2013 Jan). History of weight cycling does not impede future weight loss or metabolic improvements in postmenopausal women. Metabolism, 62(1), 127-36.
  113. Ulrich CM, Miller J (). Special Issue, Folate in Health and Disease. Mol Nutr Food Res.
  114. Abbenhardt C, Poole EM, Kulmacz RJ, Xiao L, Curtin K, Galbraith RL, Duggan D, Hsu L, Makar KW, Caan BJ, Koepl L, Owen RW, Scherer D, Carlson CS, Potter JD, Slattery ML, Ulrich CM (2013). Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. Int J Mol Epidemiol Genet, 4(3), 140-9.
  115. Seufert BL, Poole EM, Whitton J, Xiao L, Makar KW, Campbell PT, Kulmacz RJ, Baron JA, Newcomb PA, Slattery ML, Potter JD, Ulrich CM (2013 Jan). IkappaBKbeta and NFkappaB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis, 34(1), 79-85.
  116. Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM, Caan B, Kulmacz R, Whitton J, Galbraith R, Potter JD, Slattery ML (2013 Jan). PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer. Genes Nutr, 8(1), 115-26.
  117. De Roos AJ, Ulrich CM, Sjodin A, McTiernan A (2012 Nov). Adiposity, body composition, and weight change in relation to organochlorine pollutant plasma concentrations. J Expo Sci Environ Epidemiol, 22(6), 617-24.
  118. Ulrich CM, Toriola AT, Koepl LM, Sandifer T, Poole EM, Duggan C, McTiernan A, Issa JP (2012 Sep). Metabolic, hormonal and immunological associations with global DNA methylation among postmenopausal women. Epigenetics, 7(9), 1020-8.
  119. Chen CY, Poole EM, Ulrich CM, Kulmacz RJ, Wang LH (2012 Sep). Functional analysis of human thromboxane synthase polymorphic variants. Pharmacogenet Genomics, 22(9), 653-8.
  120. Ramsey SD, Holmes RS, McDermott CL, Blough DK, Petrin KL, Poole EM, Ulrich CM (2012 Sep). A comparison of approaches for association studies of polymorphisms and colorectal cancer risk. Colorectal Disease Online, 14(9), e573-86.
  121. Liu W, Poole EM, Ulrich CM, Kulmacz RJ (2012 Jul). Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1. Pharmacogenet Genomics, 22(7), 525-37.
  122. Haug U, Poole EM, Xiao L, Curtin K, Duggan D, Hsu L, Makar KW, Peters U, Kulmacz RJ, Potter JD, Koepl L, Caan BJ, Slattery ML, Ulrich CM (2012 Jun). Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer. Genes Chromosomes Cancer, 51(6), 598-605.
  123. Imayama I, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Mason CE, Wang CY, Blackburn GL, Bain CE, Thompson HJ, McTiernan A (2012 May 1). Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res, 72(9), 2314-26.
  124. Sudjaroen Y, Hull WE, Erben G, Wurtele G, Changbumrung S, Ulrich CM, Owen RW (2012 May). Isolation and characterization of ellagitannins as the major polyphenolic components of Longan (Dimocarpus longan Lour) seeds. Phytochemistry, 77, 226-37.
  125. Alfano CM, Imayama I, Neuhouser ML, Kiecolt-Glaser JK, Smith AW, Meeske K, McTiernan A, Bernstein L, Baumgartner KB, Ulrich CM, Ballard-Barbash R (2012 Apr 20). Fatigue, inflammation, and omega-3 and omega-6 fatty acid intake among breast cancer survivors. J Clin Oncol, 30(12), 1280-7.
  126. Hutter CM, Chang-Claude J, Slattery ML, Pflugeisen BM, Lin Y, Duggan D, Nan H, Lemire M, Rangrej J, Figueiredo JC, Jiao S, Harrison TA, Liu Y, Chen LS, Stelling DL, Warnick GS, Hoffmeister M, Kury S, Fuchs CS, Giovannucci E, Hazra A, Kraft P, Hunter DJ, Gallinger S, Zanke BW, Brenner H, Frank B, Ma J, Ulrich CM, White E, Newcomb PA, Kooperberg C, LaCroix AZ, Prentice RL, Jackson RD, Schoen RE, Chanock SJ, Berndt SI, Hayes RB, Caan BJ, Potter JD, Hsu L, Bezieau S, Chan AT, Hudson TJ, Peters U (2012 Apr 15). Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res, 72(8), 2036-44.
  127. Poole EM, Curtin K, Hsu L, Duggan DJ, Makar KW, Xiao L, Carlson CS, Caan BJ, Potter JD, Slattery ML, Ulrich CM (2012 Apr). Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer. Cancer Epidemiol, 36(2), e104-10.
  128. Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, Hunter DJ, Ma J, Fuchs CS, Giovannucci EL, Kraft P, Liu Y, Chen L, Jiao S, Makar KW, Taverna D, Gruber SB, Rennert G, Moreno V, Ulrich CM, Woods MO, Green RC, Parfrey PS, Prentice RL, Kooperberg C, Jackson RD, Lacroix AZ, Caan BJ, Hayes RB, Berndt SI, Chanock SJ, Schoen RE, Chang-Claude J, Hoffmeister M, Brenner H, Frank B, Bezieau S, Kury S, Slattery ML, Hopper JL, Jenkins MA, Le Marchand L, Lindor NM, Newcomb PA, Seminara D, Hudson TJ, Duggan DJ, Potter JD, Casey G (2012 Feb). Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet, 131(2), 217-34.
  129. Littman AJ, Bertram LC, Ceballos R, Ulrich CM, Ramaprasad J, McGregor B, McTiernan A (2012 Feb). Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures. Support Care Cancer, 20(2), 267-77.
  130. Ulrich CM, Steindorf K (). Cancer prevention through lifestyle - what is evidence-based? Onkologe, 18, 192-7.
  131. Campbell K, Foster-Schubert K, Alfano C, Cadmus L, Xiao L, Duggan C, Irwin M, Ulrich CM, McTiernan A (). Injuries in sedentary individuals enrolled in a 12-month randomized controlled exercise trial. J Phys Act Health, 9, 198-207.
  132. Dee A, McKean-Cowdin R, Neuhouser M, Ulrich CM, Baumgartner R, McTiernan A, Baumgartner K, Alfano C, Ballard-Barbash R, Bernstein L (). DEXA measures of body fat percentage and acute phase proteins among breast cancer survivors: A cross-sectional analysis. BMC Cancer, 12, 343.
  133. Schmidt ME, Wiskemann J, Krakowski-Roosen H, Knicker AJ, Habermann N, Schneeweiss A, Ulrich CM, Steindorf K (). Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: Design and rationale of a randomized controlled trial (BEATE study). Contemp Clin Trials, 34, 117-25.
  134. Ulrich CM, Toriola AT, Koepl LM, Sandifer T, Poole EM, Duggan C, McTiernan A, Issa JP (). Metabolic, hormonal and immunological associations with global DNA methylation among postmenopausal women. Epigenetics, 7, 1020-8.
  135. Khallouki F, Haubner R, Erben G, Ulrich CM, Owen RW (). Phytochemical composition and antioxidant capacity of various botanical parts of the fruits of Prunus x domestica L. from the Lorraine region of France. Food Chem, 133(3), 697-706.
  136. Jiao S, Hsu L, Berndt S, Bezieau S, Brenner H, Buchanan D, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock S, Conti DV, Curtis KR, Duggan D, Gallinger S, Gruber SB, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hutter CM, Jackson RD, Jenkins MA, Kantor ED, Kolonel LN, Kury S, Le Marchand L, Lemire M, Newcomb PA, Potter JD, Qu C, Rosse SA, Schoen RE, Schumacher FR, Seminara D, Slattery ML, Ulrich CM, Zanke BW, Peters U (2012). Genome-wide search for gene-gene interactions in colorectal cancer. PLoS ONE, 7(12), e52535.
  137. Reding KW, Lampe JW, Wang CY, Stanczyk FZ, Ulrich CM, Xiao L, Duggan CR, McTiernan A (2011 Dec). A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations. Cancer Epidemiol, 35(6), 569-73.
  138. Coghill AE, Newcomb PA, Poole EM, Hutter CM, Makar KW, Duggan D, Potter JD, Ulrich CM (2011 Nov 15). Genetic variation in inflammatory pathways is related to colorectal cancer survival. Clin Cancer Res, 17(22), 7139-47.
  139. Khallouki F, Haubner R, Ulrich CM, Owen RW (2011 Nov). Ethnobotanical survey, chemical composition, and antioxidant capacity of methanolic extract of the root bark of Annona cuneata Oliv. J Med Food, 14(11), 1397-402.
  140. Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D, Zaza G, Dunnenberger HM, Marsh S, McLeod HL, Giacomini K, Becker ML, Gaedigk R, Leeder JS, Kager L, Relling MV, Evans W, Klein TE, Altman RB (2011 Oct). PharmGKB summary: methotrexate pathway. Pharmacogenet Genomics, 21(10), 679-86.
  141. Mason C, Foster-Schubert KE, Imayama I, Kong A, Xiao L, Bain C, Campbell KL, Wang CY, Duggan CR, Ulrich CM, Alfano CM, Blackburn GL, McTiernan A (2011 Oct). Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med, 41(4), 366-75.
  142. Liu W, Poole EM, Ulrich CM, Kulmacz RJ (2011 Oct). Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors. Pharmacogenomics J, 11(5), 337-47.
  143. Neuhouser ML, Nijhout HF, Gregory JF 3rd, Reed MC, James SJ, Liu A, Shane B, Ulrich CM (2011 Sep). Mathematical modeling predicts the effect of folate deficiency and excess on cancer-related biomarkers. Cancer Epidemiol Biomarkers Prev, 20(9), 1912-7.
  144. Villasenor A, Ambs A, Ballard-Barbash R, Baumgartner KB, McTiernan A, Ulrich CM, Neuhouser ML (2011 Sep). Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study. Breast Cancer Res Treat, 129(2), 485-94.
  145. Slattery ML, Curtin K, Poole EM, Duggan DJ, Samowitz WS, Peters U, Caan BJ, Potter JD, Ulrich CM (2011 Jun 1). Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer, 128(11), 2726-34.
  146. George SM, Irwin ML, Smith AW, Neuhouser ML, Reedy J, McTiernan A, Alfano CM, Bernstein L, Ulrich CM, Baumgartner KB, Moore SC, Albanes D, Mayne ST, Gail MH, Ballard-Barbash R (2011 Apr). Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control, 22(4), 589-98.
  147. Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM (2011 Apr). Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer. Gut, 60(4), 491-8.
  148. Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N, Ulrich CM, Bohus M (2011 Mar 3). Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood, 117(9), 2604-13.
  149. Curtin K, Samowitz WS, Ulrich CM, Wolff RK, Herrick JS, Caan BJ, Slattery ML (2011). Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer, 63(3), 357-66.
  150. Williams L, Ulrich CM, Larson T, Wener MH, Wood B, Chen-Levy Z, Campbell PT, Potter J, McTiernan A, Roos AJ (2011). Fine particulate matter (PM(2).(5)) air pollution and immune status among women in the Seattle area. Arch Environ Occup Health, 66(3), 155-65.
  151. Wiskemann J, Ulrich CM, Steindorf K (). Effects of physical training on the psyche of cancer patients. Forum, 26, 42-8.
  152. Curtin K, Ulrich CM, Samowitz WS, Wolff RK, Duggan DJ, Makar KW, Caan BJ, Slattery ML (2011 Jan 1). Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations. Int J Mol Epidemiol Genet, 2(1), 1-8.
  153. Poole EM, Curtin K, Hsu L, Kulmacz RJ, Duggan DJ, Makar KW, Xiao L, Carlson CS, Slattery ML, Caan BJ, Potter JD, Ulrich CM (2011). Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer. Int J Mol Epidemiol Genet, 2(4), 300-15.
  154. Galbraith RL, Poole EM, Duggan D, Muehling J, Hsu L, Makar K, Xiao L, Potter JD, Ulrich CM (2011). Polymorphisms in WNT6 and WNT10A and colorectal adenoma risk. Nutr Cancer, 63(4), 558-64.
  155. Ulrich CM, Grady WM (2010 Dec). Linking epidemiology to epigenomics--where are we today? Cancer Prev Res (Phila), 3(12), 1505-8.
  156. Freedman AN, Sansbury LB, Figg WD, Potosky AL, Weiss Smith SR, Khoury MJ, Nelson SA, Weinshilboum RM, Ratain MJ, McLeod HL, Epstein RS, Ginsburg GS, Schilsky RL, Liu G, Flockhart DA, Ulrich CM, Davis RL, Lesko LJ, Zineh I, Randhawa G, Ambrosone CB, Relling MV, Rothman N, Xie H, Spitz MR, Ballard-Barbash R, Doroshow JH, Minasian LM (2010 Nov 17). Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation. J Natl Cancer Inst, 102(22), 1698-705.
  157. George SM, Neuhouser ML, Mayne ST, Irwin ML, Albanes D, Gail MH, Alfano CM, Bernstein L, McTiernan A, Reedy J, Smith AW, Ulrich CM, Ballard-Barbash R (2010 Sep). Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors. Cancer Epidemiol Biomarkers Prev, 19(9), 2220-8.
  158. Holmes RS, Zheng Y, Baron JA, Li L, McKeown-Eyssen G, Newcomb PA, Stern MC, Haile RW, Grady WM, Potter JD, Le Marchand L, Campbell PT, Figueiredo JC, Limburg PJ, Jenkins MA, Hopper JL, Ulrich CM (2010 Aug). Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev, 19(8), 2023-34.
  159. Campbell PT, Gross MD, Potter JD, Schmitz KH, Duggan C, McTiernan A, Ulrich CM (2010 Aug). Effect of exercise on oxidative stress: a 12-month randomized, controlled trial. Med Sci Sports Exerc, 42(8), 1448-53.
  160. Levine AJ, Figueiredo JC, Lee W, Conti DV, Kennedy K, Duggan DJ, Poynter JN, Campbell PT, Newcomb P, Martinez ME, Hopper JL, Le Marchand L, Baron JA, Limburg PJ, Ulrich CM, Haile RW (2010 Jul). A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 19(7), 1812-21.
  161. Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb P, Poole EM, Ulrich CM, Lindor N, Goode EL, Fridley BL, Jenkins R, Le Marchand L, Casey G, Haile R, Hopper J, Jenkins M, Young J, Buchanan D, Gallinger S, Adams M, Lewis S, Willis J, Elston R, Markowitz SD, Wiesner GL (2010 Jul 1). Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. Cancer Res, 70(13), 5409-18.
  162. Ulrich CM, James JL, Walker EM, Stine SH, Gore E, Prestidge B, Michalski J, Gwede CK, Chamberlain R, Bruner DW (2010 May). RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: implications for improving patient recruitment. Contemp Clin Trials, 31(3), 221-8.
  163. Figueiredo JC, Levine AJ, Lee WH, Conti DV, Poynter JN, Campbell PT, Duggan D, Lewinger JP, Martinez ME, Ulrich CM, Newcomb P, Potter J, Limburg PJ, Hopper J, Jenkins MA, Le Marchand L, Baron JA, Haile RW (2010 Apr). Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer Causes Control, 21(4), 597-608.
  164. Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD, Le Marchand L, Green RC, Parfrey P, Younghusband HB, Cotterchio M, Gallinger S, Jenkins MA, Hopper JL, Baron JA, Thibodeau SN, Lindor NM, Limburg PJ, Martinez ME (2010 Mar 17). Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst, 102(6), 391-400.
  165. Hooper LE, Foster-Schubert KE, Weigle DS, Sorensen B, Ulrich CM, McTiernan A (2010 Mar). Frequent intentional weight loss is associated with higher ghrelin and lower glucose and androgen levels in postmenopausal women. Nutr Res, 30(3), 163-70.
  166. Poole EM, Hsu L, Xiao L, Kulmacz RJ, Carlson CS, Rabinovitch PS, Makar KW, Potter JD, Ulrich CM (2010 Feb). Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev, 19(2), 547-57.
  167. De Roos AJ, Ulrich CM, Ray RM, Mossavar-Rahmani Y, Rosenberg CA, Caan BJ, Thomson CA, McTiernan A, LaCroix AZ (2010 Feb). Intentional weight loss and risk of lymphohematopoietic cancers. Cancer Causes Control, 21(2), 223-36.
  168. Levine AJ, Figueiredo JC, Lee W, Poynter JN, Conti D, Duggan DJ, Campbell PT, Newcomb P, Martinez ME, Hopper JL, Le Marchand L, Baron JA, Limburg PJ, Ulrich CM, Haile RW (2010 Jan). Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry. Cancer Epidemiol Biomarkers Prev, 19(1), 89-100.
  169. Chang JL, Chen G, Ulrich CM, Bigler J, King IB, Schwarz Y, Li S, Li L, Potter JD, Lampe JW (2010). DNA damage and repair: fruit and vegetable effects in a feeding trial. Nutr Cancer, 62(3), 329-35.
  170. Curtin K, Samowitz WS, Wolff RK, Ulrich CM, Caan BJ, Potter JD, Slattery ML (2009 Dec). Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev, 18(12), 3384-8.
  171. Kong A, Neuhouser ML, Xiao L, Ulrich CM, McTiernan A, Foster-Schubert KE (2009 Nov). Higher habitual intake of dietary fat and carbohydrates are associated with lower leptin and higher ghrelin concentrations in overweight and obese postmenopausal women with elevated insulin levels. Nutr Res, 29(11), 768-76.
  172. Curtin K, Samowitz WS, Wolff RK, Caan BJ, Ulrich CM, Potter JD, Slattery ML (2009 Nov). MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Mol Carcinog, 48(11), 989-94.
  173. Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Farin FM, Makar KW, Carlson CS, Caan BJ, Potter JD, Peters U (2009 Sep). Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev, 18(9), 2540-8.
  174. Wayne SJ, Neuhouser ML, Koprowski C, Ulrich CM, Wiggins C, Gilliland F, Baumgartner KB, Baumgartner RN, McTiernan A, Bernstein L, Ballard-Barbash R (2009 Sep). Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users. Breast Cancer Res Treat, 117(1), 111-9.
  175. Campbell PT, Campbell KL, Wener MH, Wood BL, Potter JD, McTiernan A, Ulrich CM (2009 Aug). A yearlong exercise intervention decreases CRP among obese postmenopausal women. Med Sci Sports Exerc, 41(8), 1533-9.
  176. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A, Ulrich CM (2009 Jul 20). Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol, 27(21), 3437-44.
  177. Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD, Slattery ML (2009 May). Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut, 58(5), 661-7.
  178. Trobridge P, Knoblaugh S, Washington MK, Munoz NM, Tsuchiya KD, Rojas A, Song X, Ulrich CM, Sasazuki T, Shirasawa S, Grady WM (2009 May). TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. Gastroenterology, 136(5), 1680-8.e7.
  179. Nijhout HF, Gregory JF, Fitzpatrick C, Cho E, Lamers KY, Ulrich CM, Reed MC (2009 Apr). A mathematical model gives insights into the effects of vitamin B-6 deficiency on 1-carbon and glutathione metabolism. J Nutr, 139(4), 784-91.
  180. Pierce BL, Neuhouser ML, Wener MH, Bernstein L, Baumgartner RN, Ballard-Barbash R, Gilliland FD, Baumgartner KB, Sorensen B, McTiernan A, Ulrich CM (2009 Mar). Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat, 114(1), 155-67.
  181. Williams LA, Ulrich CM, Larson T, Wener MH, Wood B, Campbell PT, Potter JD, McTiernan A, De Roos AJ (2009 Mar). Proximity to traffic, inflammation, and immune function among women in the Seattle, Washington, area. Environ Health Perspect, 117(3), 373-8.
  182. Poole EM, Bigler J, Whitton J, Sibert JG, Potter JD, Ulrich CM (2009 Feb). C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps. Pharmacogenet Genomics, 19(2), 113-20.
  183. Maruti SS, Ulrich CM, White E (2009 Feb). Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr, 89(2), 624-33.
  184. Campbell KL, Makar KW, Kratz M, Foster-Schubert KE, McTiernan A, Ulrich CM (2009 Jan). A pilot study of sampling subcutaneous adipose tissue to examine biomarkers of cancer risk. Cancer Prev Res (Phila), 2(1), 37-42.
  185. Maruti SS, Ulrich CM, Jupe ER, White E (2009). MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Res, 11(6), R91.
  186. Wayne SJ, Neuhouser ML, Ulrich CM, Koprowski C, Baumgartner KB, Baumgartner RN, McTiernan A, Bernstein L, Ballard-Barbash R (2008 Nov). Dietary fiber is associated with serum sex hormones and insulin-related peptides in postmenopausal breast cancer survivors. Breast Cancer Res Treat, 112(1), 149-58.
  187. Wayne S, Neuhouser ML, Ulrich CM, Koprowski C, Wiggins C, Baumgartner KB, Bernstein L, Baumgartner RN, Gilliland F, McTiernan A, Ballard-Barbash R (2008 Nov). Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors. Cancer Epidemiol Biomarkers Prev, 17(11), 3224-32.
  188. Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Caan BJ, Potter JD, Peters U (2008 Oct). Genetic variation in calcium-sensing receptor and risk for colon cancer. Cancer Epidemiol Biomarkers Prev, 17(10), 2755-65.
  189. Samowitz WS, Curtin K, Wolff RK, Albertsen H, Sweeney C, Caan BJ, Ulrich CM, Potter JD, Slattery ML (2008 Oct). The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer, 47(10), 835-44.
  190. Meyers JA, Liu AY, McTiernan A, Wener MH, Wood B, Weigle DS, Sorensen B, Chen-Levy Z, Yasui Y, Boynton A, Potter JD, Ulrich CM (2008 Oct). Serum leptin concentrations and markers of immune function in overweight or obese postmenopausal women. J Endocrinol, 199(1), 51-60.
  191. Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, Bernstein L, Wayne S, Gilliland F, Baumgartner K, Baumgartner R, Ballard-Barbash R (2008 Jul). Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr, 88(1), 133-9.
  192. Campbell KL, Campbell PT, Ulrich CM, Wener M, Alfano CM, Foster-Schubert K, Rudolph RE, Potter JD, McTiernan A (2008 Jul). No reduction in C-reactive protein following a 12-month randomized controlled trial of exercise in men and women. Cancer Epidemiol Biomarkers Prev, 17(7), 1714-8.
  193. Ulrich CM, Neuhouser M, Liu AY, Boynton A, Gregory JF 3rd, Shane B, James SJ, Reed MC, Nijhout HF (2008 Jul). Mathematical modeling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis. Cancer Epidemiol Biomarkers Prev, 17(7), 1822-31.
  194. Luebeck EG, Moolgavkar SH, Liu AY, Boynton A, Ulrich CM (2008 Jun). Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions. Cancer Epidemiol Biomarkers Prev, 17(6), 1360-7.
  195. Campbell PT, Wener MH, Sorensen B, Wood B, Chen-Levy Z, Potter JD, McTiernan A, Ulrich CM (2008 Jun). Effect of exercise on in vitro immune function: a 12-month randomized, controlled trial among postmenopausal women. J Appl Physiol, 104(6), 1648-55.
  196. Hawkins VN, Foster-Schubert K, Chubak J, Sorensen B, Ulrich CM, Stancyzk FZ, Plymate S, Stanford J, White E, Potter JD, McTiernan A (2008 Feb). Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial. Med Sci Sports Exerc, 40(2), 223-33.
  197. Jung AY, Poole EM, Bigler J, Whitton J, Potter JD, Ulrich CM (2008 Feb). DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev, 17(2), 330-8.
  198. Reed MC, Thomas RL, Pavisic J, James SJ, Ulrich CM, Nijhout HF (2008). A mathematical model of glutathione metabolism. Theor Biol Med Model, 5, 8.
  199. Boynton A, Neuhouser ML, Sorensen B, McTiernan A, Ulrich CM (2008 Jan). Predictors of diet quality among overweight and obese postmenopausal women. J Am Diet Assoc, 108(1), 125-30.
  200. Nijhout HF, Reed MC, Ulrich CM (2008). Mathematical models of folate-mediated one-carbon metabolism. Vitam Horm, 79, 45-82.
  201. Boynton A, Neuhouser ML, Wener MH, Wood B, Sorensen B, Chen-Levy Z, Kirk EA, Yasui Y, Lacroix K, McTiernan A, Ulrich CM (2007 Nov). Associations between healthy eating patterns and immune function or inflammation in overweight or obese postmenopausal women. Am J Clin Nutr, 86(5), 1445-55.
  202. Abrahamson PE, King IB, Ulrich CM, Rudolph RE, Irwin ML, Yasui Y, Surawicz C, Lampe JW, Lampe PD, Morgan A, Sorensen BE, Ayub K, Potter JD, McTiernan A (2007 Nov). No effect of exercise on colon mucosal prostaglandin concentrations: a 12-month randomized controlled trial. Cancer Epidemiol Biomarkers Prev, 16(11), 2351-6.
  203. Abrahamson PE, Tworoger SS, Aiello EJ, Bernstein L, Ulrich CM, Gilliland FD, Stanczyk FZ, Baumgartner R, Baumgartner K, Sorensen B, Ballard-Barbash R, McTiernan A (2007 Sep). Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors. Breast Cancer Res Treat, 105(1), 45-54.
  204. Campbell KL, McTiernan A, Li SS, Sorensen BE, Yasui Y, Lampe JW, King IB, Ulrich CM, Rudolph RE, Irwin ML, Surawicz C, Ayub K, Potter JD, Lampe PD (2007 Sep). Effect of a 12-month exercise intervention on the apoptotic regulating proteins Bax and Bcl-2 in colon crypts: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev, 16(9), 1767-74.
  205. Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS (2007 Aug). Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis, 28(8), 1672-9.
  206. Rhew I, Yasui Y, Sorensen B, Ulrich CM, Neuhouser ML, Tworoger SS, Chubak J, Bowen DJ, McTiernan A (2007 Jul). Effects of an exercise intervention on other health behaviors in overweight/obese post-menopausal women. Contemp Clin Trials, 28(4), 472-81.
  207. Poole EM, Bigler J, Whitton J, Sibert JG, Kulmacz RJ, Potter JD, Ulrich CM (2007 Jun). Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps. Carcinogenesis, 28(6), 1259-63.
  208. Curtin K, Ulrich CM, Samowitz WS, Bigler J, Caan B, Potter JD, Slattery ML (2007 May 15). Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. Int J Cancer, 120(10), 2226-32.
  209. Tworoger SS, Sorensen B, Chubak J, Irwin M, Stanczyk FZ, Ulrich CM, Potter J, McTiernan A (2007 May). Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev, 16(5), 895-9.
  210. Littman AJ, Vitiello MV, Foster-Schubert K, Ulrich CM, Tworoger SS, Potter JD, Weigle DS, McTiernan A (2007 Mar). Sleep, ghrelin, leptin and changes in body weight during a 1-year moderate-intensity physical activity intervention. Int J Obes (Lond), 31(3), 466-75.
  211. Bigler J, Sibert JG, Poole EM, Carlson CS, Potter JD, Ulrich CM (2007 Mar). Polymorphisms predicted to alter function in prostaglandin E2 synthase and prostaglandin E2 receptors. Pharmacogenet Genomics, 17(3), 221-7.
  212. Nijhout HF, Reed MC, Ulrich CM (). A day in the life of cell metabolism. Biol Theory, 2, 124-7.
  213. Rhew I, Yasui Y, Sorensen B, Ulrich CM, Neuhouser M, Potter JD, Tworoger SS, Chubak, Bowen DJ, McTiernan A (). Minimal effects of an exercise intervention trial on self-reported health behaviors in obese post-menopausal women. Contemp Clin Trials, 28, 472-81.
  214. Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Chen C (2006 Dec). Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association. Gynecol Oncol, 103(3), 891-6.
  215. Chubak J, McTiernan A, Sorensen B, Wener MH, Yasui Y, Velasquez M, Wood B, Rajan KB, Wetmore CM, Potter JD, Ulrich CM (2006 Nov). Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. Am J Med, 119(11), 937-42.
  216. Reed MC, Nijhout HF, Neuhouser ML, Gregory JF 3rd, Shane B, James SJ, Boynton A, Ulrich CM (2006 Oct). A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr, 136(10), 2653-61.
  217. Robien K, Bigler J, Yasui Y, Potter JD, Martin P, Storb R, Ulrich CM (2006 Sep). Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant, 12(9), 973-80.
  218. Chang JL, Chen G, Lampe JW, Ulrich CM (2006 Aug). DNA damage and repair measurements from cryopreserved lymphocytes without cell culture--a reproducible assay for intervention studies. Environ Mol Mutagen, 47(7), 503-8.
  219. Chubak J, Ulrich CM, Tworoger SS, Sorensen B, Yasui Y, Irwin ML, Stanczyk FZ, Potter JD, McTiernan A (2006 Jul). Effect of exercise on bone mineral density and lean mass in postmenopausal women. Med Sci Sports Exerc, 38(7), 1236-44.
  220. Yu JH, Bigler J, Whitton J, Potter JD, Ulrich CM (2006 Jun). Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking. Am J Gastroenterol, 101(6), 1313-9.
  221. Robien K, Schubert MM, Yasui Y, Martin P, Storb R, Potter JD, Ulrich CM (2006 Apr). Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation. Bone Marrow Transplant, 37(7), 687-92.
  222. Ulrich CM, Bigler J, Potter JD (2006 Apr). Genetic tools to tailor cancer prevention by NSAIDs. Discov Med, 6(32), 71-4.
  223. Nijhout HF, Reed MC, Anderson DF, Mattingly JC, James SJ, Ulrich CM (2006 Apr-Jun). Long-range allosteric interactions between the folate and methionine cycles stabilize DNA methylation reaction rate. Epigenetics, 1(2), 81-7.
  224. Poole EM, Bigler J, Whitton J, Sibert JG, Potter JD, Ulrich CM (2006 Mar). Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev, 15(3), 502-8.
  225. Mohanka M, Irwin M, Heckbert SR, Yasui Y, Sorensen B, Chubak J, Tworoger SS, Ulrich CM, McTiernan A (2006 Feb). Serum lipoproteins in overweight/obese postmenopausal women: a one-year exercise trial. Med Sci Sports Exerc, 38(2), 231-9.
  226. Ulrich CM, Potter JD (2006 Feb). Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev, 15(2), 189-93.
  227. Nijhout HF, Reed MC, Lam SL, Shane B, Gregory JF 3rd, Ulrich CM (2006). In silico experimentation with a model of hepatic mitochondrial folate metabolism. Theor Biol Med Model, 3, 40.
  228. Bowen DJ, Fesinmeyer MD, Yasui Y, Tworoger S, Ulrich CM, Irwin ML, Rudolph RE, LaCroix KL, Schwartz RR, McTiernan A (2006). Randomized trial of exercise in sedentary middle aged women: effects on quality of life. Int J Behav Nutr Phys Act, 3, 34.
  229. Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, Selhub J, McTiernan A, Yasui Y, Oral E, Potter JD, Ulrich CM (2006 Jan). Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr, 136(1), 189-94.
  230. Bigler J, Ulrich CM, Kawashima T, Whitton J, Potter JD (2005 Nov). DNA repair polymorphisms and risk of colorectal adenomatous or hyperplastic polyps. Cancer Epidemiol Biomarkers Prev, 14(11 Pt 1), 2501-8.
  231. Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Voigt LF, Chen C (2005 Nov). Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev, 14(11 Pt 1), 2524-30.
  232. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML (2005 Nov). Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 14(11 Pt 1), 2509-16.
  233. Ulrich CM (2005 Nov). Nutrigenetics in cancer research--folate metabolism and colorectal cancer. J Nutr, 135(11), 2698-702.
  234. Ulrich CM, Carlson CS, Sibert J, Poole EM, Yu JH, Wang LH, Sparks R, Potter JD, Bigler J (2005 Oct). Thromboxane synthase (TBXAS1) polymorphisms in African-American and Caucasian populations: evidence for selective pressure. Hum Mutat, 26(4), 394-5.
  235. Ulrich CM, Curtin K, Samowitz W, Bigler J, Potter JD, Caan B, Slattery ML (2005 Oct). MTHFR variants reduce the risk of G:C->A:T transition mutations within the p53 tumor suppressor gene in colon tumors. J Nutr, 135(10), 2462-7.
  236. Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A (2005 Oct). Associations between reproductive and menstrual factors and postmenopausal androgen concentrations. J Womens Health (Larchmt), 14(8), 704-12.
  237. Tien JH, Hazelton WD, Sparks R, Ulrich CM (2005 Jul). A Michaelis-Menten-style model for the autocatalytic enzyme prostaglandin H synthase. Bull Math Biol, 67(4), 683-700.
  238. Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, Irwin M, McTiernan A (2005 Jun). Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev, 14(6), 1411-7.
  239. Robien K, Curtin K, Ulrich CM, Bigler J, Samowitz W, Caan B, Potter JD, Slattery ML (2005 May). Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev, 14(5), 1350-2.
  240. McTiernan A, Sorensen B, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Rudolph RE, Stanczyk FZ, Schwartz RS, Potter JD (2005 Apr). No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev, 14(4), 1020-1.
  241. Frank LL, Sorensen BE, Yasui Y, Tworoger SS, Schwartz RS, Ulrich CM, Irwin ML, Rudolph RE, Rajan KB, Stanczyk F, Bowen D, Weigle DS, Potter JD, McTiernan A (2005 Mar). Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res, 13(3), 615-25.
  242. Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J (2005 Mar). PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Cancer Epidemiol Biomarkers Prev, 14(3), 616-9.
  243. Meyers JA, McTiernan A, Ulrich CM (). Leptin and immune function – integrating the evidence. Nutr Res, 9, 791-803.
  244. Nijhout HF, Reed MC, Budu P, Ulrich CM (2004 Dec 31). A mathematical model of the folate cycle: new insights into folate homeostasis. J Biol Chem, 279(53), 55008-16.
  245. Irwin ML, Tworoger SS, Yasui Y, Rajan B, McVarish L, LaCroix K, Ulrich CM, Bowen D, Schwartz RS, Potter JD, McTiernan A (2004 Dec). Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women. Prev Med, 39(6), 1080-6.
  246. Robien K, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B, Potter JD, Radich JP (2004 Nov 15). Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin Cancer Res, 10(22), 7592-8.
  247. Sparks R, Bigler J, Sibert JG, Potter JD, Yasui Y, Ulrich CM (2004 Oct). TGFbeta1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps. Int J Epidemiol, 33(5), 955-61.
  248. Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A (2004 Aug). Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev, 13(8), 1296-301.
  249. Hazelton WD, Tien JH, Donato VW, Sparks R, Ulrich CM (2004 Aug 1). Prostaglandin H synthases: members of a class of quasi-linear threshold switches. Biochem Pharmacol, 68(3), 423-32.
  250. Aiello EJ, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Bowen D, Schwartz RS, Kumai C, Potter JD, McTiernan A (2004 Jul-Aug). Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause, 11(4), 382-8.
  251. McTiernan A, Tworoger SS, Rajan KB, Yasui Y, Sorenson B, Ulrich CM, Chubak J, Stanczyk FZ, Bowen D, Irwin ML, Rudolph RE, Potter JD, Schwartz RS (2004 Jul). Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev, 13(7), 1099-105.
  252. Shade ED, Ulrich CM, Wener MH, Wood B, Yasui Y, Lacroix K, Potter JD, McTiernan A (2004 Jun). Frequent intentional weight loss is associated with lower natural killer cell cytotoxicity in postmenopausal women: possible long-term immune effects. J Am Diet Assoc, 104(6), 903-12.
  253. Tworoger SS, Chubak J, Aiello EJ, Yasui Y, Ulrich CM, Farin FM, Stapleton PL, Irwin ML, Potter JD, Schwartz RS, McTiernan A (2004 Jun). The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women. Obes Res, 12(6), 972-81.
  254. Atkinson C, Lampe JW, Tworoger SS, Ulrich CM, Bowen D, Irwin ML, Schwartz RS, Rajan BK, Yasui Y, Potter JD, McTiernan A (2004 May). Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev, 13(5), 868-74.
  255. Ulrich CM, Bigler J, Sparks R, Whitton J, Sibert JG, Goode EL, Yasui Y, Potter JD (2004 May). Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev, 13(5), 889-93.
  256. McTiernan A, Tworoger SS, Ulrich CM, Yasui Y, Irwin ML, Rajan KB, Sorensen B, Rudolph RE, Bowen D, Stanczyk FZ, Potter JD, Schwartz RS (2004 Apr 15). Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res, 64(8), 2923-8.
  257. Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM (2004 Apr 1). Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol, 22(7), 1268-75.
  258. Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM (2004 Feb). MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 13(2), 285-92.
  259. Reed MC, Nijhout HF, Sparks R, Ulrich CM (2004 Jan 7). A mathematical model of the methionine cycle. J Theor Biol, 226(1), 33-43.
  260. Sparks R, Ulrich CM, Bigler J, Tworoger SS, Yasui Y, Rajan KB, Porter P, Stanczyk FZ, Ballard-Barbash R, Yuan X, Lin MG, McVarish L, Aiello EJ, McTiernan A (2004). UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res, 6(5), R488-98.
  261. Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, Stanczyk FZ, McTiernan A (2004 Jan). Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev, 13(1), 94-101.
  262. Goode EL, Potter JD, Bigler J, Ulrich CM (2004 Jan). Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev, 13(1), 157-62.
  263. Tworoger SS, Yasui Y, Vitiello MV, Schwartz RS, Ulrich CM, Aiello EJ, Irwin ML, Bowen D, Potter JD, McTiernan A (2003 Nov 1). Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women. Sleep, 26(7), 830-6.
  264. Grembowski D, Ulrich CM, Paschane D, Diehr P, Katon W, Martin D, Patrick DL, Velicer C (2003 Sep-Oct). Managed care and primary physician satisfaction. J Am Board Fam Pract, 16(5), 383-93.
  265. Irwin ML, Yasui Y, Ulrich CM, Bowen D, Rudolph RE, Schwartz RS, Yukawa M, Aiello E, Potter JD, McTiernan A (2003 Jan 15). Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA, 289(3), 323-30.
  266. Mitchell BL, Ulrich CM, McTiernan A (). Supplementation with vitamins or minerals and immune function: Can the elderly benefit? Nutr Res, 23, 1117-39.
  267. Ulrich CM, Bigler J, Sibert J, Greene EA, Sparks R, Carlson CS, Potter JD (2002 Nov). Cyclooxygenase 1 (COX1) polymorphisms in African-American and Caucasian populations. Hum Mutat, 20(5), 409-10.
  268. Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD (2002 Oct). Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev, 11(10 Pt 1), 1012-8.
  269. Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD (2002 Jun 15). Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res, 62(12), 3361-4.
  270. Tworoger SS, Yasui Y, Ulrich CM, Nakamura H, LaCroix K, Johnston R, McTiernan A (2002 Jan). Mailing strategies and recruitment into an intervention trial of the exercise effect on breast cancer biomarkers. Cancer Epidemiol Biomarkers Prev, 11(1), 73-7.
  271. Girndt M, Sester U, Sester M, Deman E, Ulrich C, Kaul H, Kohler H (2001 Dec). The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. Kidney Int, 60(6), 2385-91.
  272. Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, Potter JD (2001 Aug). Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev, 10(8), 875-82.
  273. Kim HS, Newcomb PA, Ulrich CM, Keener CL, Bigler J, Farin FM, Bostick RM, Potter JD (2001 Aug). Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiol Biomarkers Prev, 10(8), 869-74.
  274. Ulrich CM, Yasui Y, Storb R, Schubert MM, Wagner JL, Bigler J, Ariail KS, Keener CL, Li S, Liu H, Farin FM, Potter JD (2001 Jul 1). Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood, 98(1), 231-4.
  275. Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM, Potter JD (2000 Dec). Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev, 9(12), 1381-5.
  276. Grembowski DE, Diehr P, Novak LC, Roussel AE, Martin DP, Patrick DL, Williams B, Ulrich CM (2000 Aug). Measuring the "managedness" and covered benefits of health plans. Health Serv Res, 35(3), 707-34.
  277. Ulrich CM, Kampman E, Bigler J, Schwartz SM, Chen C, Bostick R, Fosdick L, Beresford SA, Yasui Y, Potter JD (2000 Apr). Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps. Cancer Epidemiol Biomarkers Prev, 9(4), 427-33.
  278. Ulrich CM, Kampman E, Bigler J, Schwartz SM, Chen C, Bostick R, Fosdick L, Beresford SA, Yasui Y, Potter JD (1999 Aug). Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev, 8(8), 659-68.
  279. Ulrich CM, Georgiou CC, Gillis DE, Snow CM (1999 Apr). Lifetime physical activity is associated with bone mineral density in premenopausal women. J Womens Health, 8(3), 365-75.
  280. McTiernan A, Ulrich C, Kumai C, Bean D, Schwartz R, Mahloch J, Hastings R, Gralow J, Potter JD (1998 Jun). Anthropometric and hormone effects of an eight-week exercise-diet intervention in breast cancer patients: results of a pilot study. Cancer Epidemiol Biomarkers Prev, 7(6), 477-81.
  281. Rttger-Liepmann B, Ulrich CM, Laaser U (). Acceptance of genetic testing in the population. Fortschr Med, 116(27), 43.
  282. Rttger-Liepmann B, Ulrich CM, Laaser U (). Telephone survey on genetic testing for breast and prostate cancer risk. Fortschr Med, 116(Suppl 3), 95-9.
  283. Ulrich CM, Kristal AR, White E, Hunt JR, Durfy SJ, Potter JD (1998). Genetic testing for cancer risk: a population survey on attitudes and intention. Community Genet, 1(4), 213-22.
  284. Ulrich CM, Kristal AR, Durfy SJ, Hunt JR, White E (1996 Oct). Attitudes toward genetic testing for cancer risk among Washington State residents. Am J Hum Genet, 59(4), A340.
  285. Ulrich CM, Georgiou CC, Snow-Harter CM, Gillis DE (1996 Jan). Bone mineral density in mother-daughter pairs: relations to lifetime exercise, lifetime milk consumption, and calcium supplements. Am J Clin Nutr, 63(1), 72-9.
  286. Ulrich CM (). WHO – An Internship Experience. Z Gesundh Wiss, 2, 275-82.

Review

  1. Blumberg JB, Bailey RL, Sesso HD, Ulrich CM (2018 Feb 22). The Evolving Role of Multivitamin/Multimineral Supplement Use among Adults in the Age of Personalized Nutrition.LID - E248 [pii]LID - 10.3390/nu10020248 [doi]. [Review]. Nutrients, 10(2).
  2. Himbert C, Delphan M, Scherer D, Bowers LW, Hursting S, Ulrich CM (2017 Sep). Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review. [Review]. Cancer Prev Res (Phila), 10(9), 494-506.
  3. Himbert C, Ose J, Delphan M, Ulrich CM (2017 Feb). A systematic review of the interrelation between diet- and surgery-induced weight loss and vitamin D status. [Review]. Nutr Res, 38, 13-26.
  4. Skender S, Ose J, Chang-Claude J, Paskow M, Bruhmann B, Siegel EM, Steindorf K, Ulrich CM (2016 Jun 16). Accelerometry and physical activity questionnaires - a systematic review. [Review]. BMC Public Health, 16, 515.
  5. Beyerle J, Frei E, Stiborova M, Habermann N, Ulrich CM (2015 May). Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer. [Review]. Drug Metab Rev, 47(2), 199-221.
  6. Brenner DR, Scherer D, Muir K, Schildkraut J, Boffetta P, Spitz MR, Le Marchand L, Chan AT, Goode EL, Ulrich CM, Hung RJ (2014 Sep). A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research. [Review]. Cancer Epidemiol Biomarkers Prev, 23(9), 1729-51.
  7. Strasser B, Steindorf K, Wiskemann J, Ulrich CM (2013 Nov). Impact of resistance training in cancer survivors: a meta-analysis. [Review]. Med Sci Sports Exerc, 45(11), 2080-90.
  8. Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bezieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Chen LS, Coetzee GA, Coetzee SG, Conti DV, Curtis KR, Duggan D, Edwards T, Fuchs CS, Gallinger S, Giovannucci EL, Gogarten SM, Gruber SB, Haile RW, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hunter DJ, Jackson RD, Jee SH, Jenkins MA, Jia WH, Kolonel LN, Kooperberg C, Kury S, Lacroix AZ, Laurie CC, Laurie CA, Le Marchand L, Lemire M, Levine D, Lindor NM, Liu Y, Ma J, Makar KW, Matsuo K, Newcomb PA, Potter JD, Prentice RL, Qu C, Rohan T, Rosse SA, Schoen RE, Seminara D, Shrubsole M, Shu XO, Slattery ML, Taverna D, Thibodeau SN, Ulrich CM, White E, Xiang Y, Zanke BW, Zeng YX, Zhang B, Zheng W, Hsu L (2013 Apr). Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. [Review]. Gastroenterology, 144(4), 799-807.e24.
  9. Elena JW, Travis LB, Simonds NI, Ambrosone CB, Ballard-Barbash R, Bhatia S, Cerhan JR, Hartge P, Heist RS, Kushi LH, Lash TL, Morton LM, Onel K, Pierce JP, Robison LL, Rowland JH, Schrag D, Sellers TA, Seminara D, Shu XO, Thomas NE, Ulrich CM, Freedman AN (2013 Jan 16). Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. [Review]. J Natl Cancer Inst, 105(2), 85-94.
  10. Siegel EM, Ulrich CM, Poole EM, Holmes RS, Jacobsen PB, Shibata D (2010 Jan). The effects of obesity and obesity-related conditions on colorectal cancer prognosis. [Review]. Cancer Control, 17(1), 52-7.
  11. Thomas DC, Conti DV, Baurley J, Nijhout F, Reed M, Ulrich CM (2009 Oct). Use of pathway information in molecular epidemiology. [Review]. Hum Genomics, 4(1), 21-42.
  12. Ulrich CM (2008 Sep). Folate and cancer prevention--where to next? Counterpoint. [Review]. Cancer Epidemiol Biomarkers Prev, 17(9), 2226-30.
  13. Cross JT, Poole EM, Ulrich CM (2008 Aug). A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia. [Review]. Pharmacogenomics J, 8(4), 237-47.
  14. Ulrich CM, Reed MC, Nijhout HF (2008 Aug). Modeling folate, one-carbon metabolism, and DNA methylation. [Review]. Nutr Rev, 66 Suppl 1, S27-30.
  15. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U (2008 May 28). Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. [Review]. JAMA, 299(20), 2423-36.
  16. Velicer CM, Ulrich CM (2008 Feb 1). Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. [Review]. J Clin Oncol, 26(4), 665-73.
  17. Grady WM, Ulrich CM (2007 Mar). DNA alkylation and DNA methylation: cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas? [Review]. Gut, 56(3), 318-20.
  18. Ambrosone CB, Rebbeck TR, Morgan GJ, Albain KS, Calle EE, Evans WE, Hayes DF, Kushi LH, McLeod HL, Rowland JH, Ulrich CM (2006 Nov). New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival. [Review]. Cancer Epidemiol Biomarkers Prev, 15(11), 2042-6.
  19. Ulrich CM, Bigler J, Potter JD (2006 Feb). Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. [Review]. Nat Rev Cancer, 6(2), 130-40.
  20. Robien K, Boynton A, Ulrich CM (2005 Oct). Pharmacogenetics of folate-related drug targets in cancer treatment. [Review]. Pharmacogenomics, 6(7), 673-89.
  21. Weiss JM, Goode EL, Ladiges WC, Ulrich CM (2005 Mar). Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. [Review]. Mol Carcinog, 42(3), 127-41.
  22. Ulrich CM, Robien K, McLeod HL (2003 Dec). Cancer pharmacogenetics: polymorphisms, pathways and beyond. [Review]. Nat Rev Cancer, 3(12), 912-20.
  23. Chang CK, Ulrich CM (2003 May). Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients. [Review]. Diabetologia, 46(5), 595-607.
  24. Robien K, Ulrich CM (2003 Apr 1). 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. [Review]. Am J Epidemiol, 157(7), 571-82.
  25. Goode EL, Ulrich CM, Potter JD (2002 Dec). Polymorphisms in DNA repair genes and associations with cancer risk. [Review]. Cancer Epidemiol Biomarkers Prev, 11(12), 1513-30.
  26. Ulrich CM, Robien K, Sparks R (2002 May). Pharmacogenetics and folate metabolism -- a promising direction. [Review]. Pharmacogenomics, 3(3), 299-313.
  27. McTiernan A, Ulrich C, Slate S, Potter J (1998 Oct). Physical activity and cancer etiology: associations and mechanisms. [Review]. Cancer Causes Control, 9(5), 487-509.

Book

  1. Ulrich CM, Steindorf K, Berger N (). Exercise, Energy Balance, and Cancer. New York: Springer Science and Business Media.

Book Chapter

  1. Wiskemann J, Ulrich CM (). Exercise during stem cell transplantation. In Ulrich CM, Steindorf K, Berger NA (Eds.), Exercise, Energy Balance, and Cancer (pp. 119-42). New York: Springer Science and Business Media.
  2. Ulrich CM, Xu X, Liu AY, Chen J (). Folate. In Milner JA and Romagnolo DF (Eds.), Bioactive Compounds and Cancer (pp. 387-410). London: Humana Press.
  3. Chen J, Xu X, Liu AY, Ulrich CM (). Folate and Cancer: Epidemiological Perspective. In Bailey LB (Ed.), Folate in Health and Disease (2nd Edition, pp. 205-34). Boca Raton, FL: CRC Press, Taylor & Francis Group.
  4. Poole EM, Cross JT, Potter JD, Ulrich CM (). Genetic Variability in NSAID targets and NSAID-metabolizing enzymes and colorectal neoplasia. In Potter JD and Lindor NM (Eds.), Genetics of colorectal cancer (pp. 243-60). New York: Springer.
  5. Liu AY, Ulrich CM (). Genetic variability in folate-mediated one-carbon metabolism and risk of colorectal neoplasia. In Potter JD and Lindor NM (Eds.), Genetics of colorectal cancer (pp. 223-42). New York: Springer Science and Business Media.
  6. Ulrich CM, Ambrosone CB (). Molecular epidemiological designs for prognosis. In Rebbeck T, Ambrosone C, Shields P (Eds.), Molecular Epidemiology (pp. 41-52). Taylor & Francis, Inc.
  7. Ulrich CM (). Genetic variability in folate-mediated one-carbon metabolism and cancer risk. In Choi SW and Friso S (Eds.), Nutrients and gene interactions in cancer (pp. 75-91).
  8. Wetmore CM, Ulrich CM (). Mechanisms associating physical activity with cancer incidence: Exercise and immune function. In McTiernan A (Ed.), Cancer Prevention and Management through Exercise and Weight Control (pp. 157-75). Boca Raton, FL: Taylor & Francis Group, LLC.

Conference Proceedings

  1. Ulrich CM, Potter JD (). Diet, genes, and cancer risk. German Senate Commission on Food Safety (SKLM) Proceedings, 37-49.

Commentary

  1. Ulrich CM (). Aspirin for cancer prevention? Oncology Today.

Editorial

  1. Ulrich CM, Miller JW (2013 Apr). Folate and health: present and future. Mol Nutr Food Res, 57(4), 561.
  2. Toriola AT, Ulrich CM (2011 Oct). Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer? Future Oncol, 7(10), 1125-8.
  3. Ulrich CM, Holmes RS (2008 Jun 20). Shedding light on colorectal cancer prognosis: vitamin d and beyond. J Clin Oncol, 26(18), 2937-9.
  4. Ulrich CM (2007 Aug). Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr, 86(2), 271-3.
  5. Ulrich CM, Potter JD (2007 Jun 6). Folate and cancer--timing is everything. JAMA, 297(21), 2408-9.
  6. Potter JD, Ulrich CM (2006 Jun). COX-2 and gastric cancer: More on inflammation and neoplasia. Gastroenterology, 130(7), 2198-200.
  7. Ulrich CM, Nijhout HF, Reed MC (2006 May). Mathematical modeling: epidemiology meets systems biology. Cancer Epidemiol Biomarkers Prev, 15(5), 827-9.

Letter

  1. Paleari L, Burhenne J, Weiss J, Foersch S, Roth W, Parodi A, Gnant M, Bachleitner-Hofmann T, Scherer D, Ulrich CM, Stabuc B, Puntoni M, Coccia G, Petrera M, Haefeli WE, DeCensi A (2018 Apr). High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic Syndrome [Letter to the editor]. Gastroenterology, 154(5), 1543-1545.
  2. Abbenhardt C, Ulrich CM (2013 Dec). Response to Dr. Sarlak et al.: letter to the editor 'A larger weight reduction is necessary to elicit an increase in adiponectin and a decrease in leptin levels' [Letter to the editor]. J Intern Med, 274(6), 615.
  3. Ulrich CM, Chubak J, McTiernan A (). Re: Exercise, vitamins and respiratory tract infections [Letter to the editor]. Am J Med, 120, e19.
  4. Robien K, Schubert MM, Chay T, Bigler J, Storb R, Yasui Y, Potter JD, Ulrich CM (2006 Apr). Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation [Letter to the editor]. Bone Marrow Transplant, 37(8), 799-800.
  5. Ulrich CM, Potter JD (2002 Apr 22). Thymidylate synthase polymorphism and survival of colorectal cancer patients treated with 5-fluorouracil [Letter to the editor]. Br J Cancer, 86(8), 1365; author reply 1366.
  6. Ulrich CM, Potter JD (2001 Oct 17). Testing for colon neoplasia susceptibility variants at the human Cox2 locus [Letter to the editor]. J Natl Cancer Inst, 93(20), 1572-4.

Abstract

  1. Hubner J, Marienfeld S, Abbenhardt C, Ulrich CM, Loser C (2012 Nov). [How useful are diets against cancer?] [Abstract]. Dtsch Med Wochenschr, 137(47), 2417-22.
  2. Steindorf K, Schmidt M, Ulrich C (2012 Jan). [Effects of physical activity on cancer risk and disease progression after cancer diagnosis] [Abstract]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 55(1), 10-6.
  3. Ulrich CM, Wiskemann J, Steindorf K (2012 Jan). [Physiologic and molecular mechanisms linking physical activity to cancer risk and progression] [Abstract]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 55(1), 3-9.

Other

  1. Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucci EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Kury S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G, Gruber SB, Peters U (2015 Oct 26). Corrigendum: genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun (6, p. 8739). England.
  2. Boffetta P, Colditz GA, Potter JD, Kolonel L, Robson PJ, Malekzadeh R, Seminara D, Goode EL, Yoo KY, Demers P, Gallagher R, Prentice R, Yasui Y, ODoherty K, Petersen GM, Ulrich CM, Csizmadi I, Amankwah EK, Brockton NT, Kopciuk K, McGregor SE, Kelemen LE (2011 Mar). Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009). Cancer Causes Control (22(3), pp. 463-8). Netherlands.

News

Video